Email Alert | RSS    帮助

中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (7): 694-701.doi: 10.3969/j.issn.1000-6621.2021.07.010

• 论著 • 上一篇    下一篇

初治与复治空洞性利福平耐药肺结核患者的CT表现分析

曹盼, 梁矿立, 袁吉欣, 李永波, 陈瑞, 张志飞, 仵倩红*()   

  1. 710100 西安,陕西省结核病防治院 陕西省第五人民医院
  • 收稿日期:2021-03-01 出版日期:2021-07-10 发布日期:2021-07-09
  • 通信作者: 仵倩红 E-mail:15902969531@126.com
  • 基金资助:
    陕西省卫生健康科研项目(2021D027)

Analysis of CT findings in patients with initial and retreated cavernous rifampicin-resistant tuberculosis

CAO Pan, LIANG Kuang-li, YUAN Ji-xin, LI Yong-bo, CHEN Rui, ZHANG Zhi-fei, WU Qian-hong*()   

  1. Tuberculosis Hospital of Shannxi Province,the Fifth People’s Hospital of Shaanxi Province, Xi’an 710100, China
  • Received:2021-03-01 Online:2021-07-10 Published:2021-07-09
  • Contact: WU Qian-hong E-mail:15902969531@126.com

摘要: 目的 对比分析初治与复治空洞性利福平耐药肺结核患者的CT表现。 方法 收集2020年1月至2021年1月陕西省结核病防治院经药物敏感性试验确诊的72例空洞性利福平耐药肺结核患者,按照治疗史将患者分为初治组(34例)和复治组(38例)。分析两组患者一般临床资料、空洞和非空洞CT表现的差异,对两组患者空洞数量、空洞最大内径、空洞壁钙化、肺实变、毁损肺、肺气肿、肺内钙化灶等CT表现进行比较分析。 结果 两组空洞病变CT表现对比显示,复治组空洞数量中位数(四分位数)[5.0(2.0,10.0)个]与初治组空洞数量中位数(四分位数)[2.0(1.0,5.0)个]比较差异有统计学意义(Z=2.020,P<0.05);复治组空洞最大内径中位数(四分位数)[19.40(13.09,34.09)mm]与初治组空洞最大内径中位数(四分位数)[12.31(5.35,22.97)mm]比较差异有统计学意义(Z=2.662,P<0.05);复治组发生空洞壁钙化率[42.11%(16/38)]与初治组[17.65%(6/34)]相比差异有统计学意义(χ 2=5.059,P<0.05)。两组非空洞性病变CT征象对比显示,复治组肺实变发生率[78.95%(30/38)]、毁损肺发生率[39.47%(15/38)]、肺气肿发生率[39.47%(15/38)]、肺内钙化灶发生率[52.63%(20/38)],与初治组[分别为52.94%(18/34)、17.65%(6/34)、14.71%(5/34)、23.53%(8/34)]比较,差异均有统计学意义(χ 2值分别为5.461、4.138、5.487、6.395,P值均<0.05)。 结论 复治空洞性利福平耐药肺结核患者比初治患者空洞数量多、空洞最大内径大,同时,空洞壁钙化、肺实变、毁损肺、肺气肿、肺内钙化灶等CT表现也比初治患者严重。

关键词: 结核, 肺, X线计算机, 体层摄影术, 利福平, 抗药性, 细菌

Abstract: Objective To comparatively analyze the CT findings in patients with initial and retreated cavernous rifampicin-resistant tuberculosis. Methods From January 2020 to January 2021, 72 cavernous rifampicin-resistant tuberculosis patients confirmed by drug sensitivity test at Tuberculosis Hospital of Shannxi Province were collected and divided into initial treatment group (n=34) and retreatment group (n=38) according to the treatment history. Differences in the general clinical data, cavernous and non-cavernous CT findings between two groups were analyzed. Besides, CT findings in two groups, including cavity number, maximum inner diameter of cavity, cavity wall calcification, lung consolidation, destructive lung, emphysema and intrapulmonary calcification were comparatively analyzed. Results As revealed by comparisons of cavity lesion CT findings between two groups, the median cavity number in retreatment group was 5.0 (2.0, 10.0), while that in initial treatment group was 2.0 (1.0, 5.0), and the difference was of statistical significance (Z=2.020, P<0.05). The maximum inner diameter of cavity in retreatment group was 19.40 (13.09,34.09) mm, while that in initial treatment group was 12.31 (5.35,22.97) mm, and the difference was of statistical significance (Z=2.662, P<0.05). The rate of cavity wall calcification in retreatment group was 42.11% (16/38), while that in initial treatment group was 17.65% (6/34), and the difference was statistically significant (χ 2=5.059, P<0.05). When comparing the CT signs of non-cavity lesions between two groups, the rates of lung consolidation, destroyed lungs, emphysema and intrapulmonary calcification in retreatment group were 78.95% (30/38), 39.47% (15/38), 39.47% (15/38), 52.63% (20/38), respectively; while those in initial treatment group were 52.94% (18/34), 17.65% (6/34), 14.71% (5/34), 23.53% (8/34), separately, and the differences were of statistical significance (χ 2 values were 5.461, 4.138, 5.487 and 6.395, respectively; allP<0.05). Conclusion Compared with initial treatment patients, retreated cavernous rifampicin-resistant tuberculosis patients had more cavities, greater maximum inner diameter of cavity, along with more severe CT findings of cavity wall calcification, lung consolidation, destroyed lungs, emphysema and intrapulmonary calcification.

Key words: Tuberculosis, pulmonary, X-ray computed, tomography, Rifampicin, Drug resistance, bacterium